# Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

> **NCT02019212** · — · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 4000 (estimated)

## Conditions studied

- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02019212
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-10-27
- **Final completion:** 2016-10-27
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019212, "Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02019212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*